Cargando…

Iron Sucrose: A Wealth of Experience in Treating Iron Deficiency

Iron deficiency and iron-deficiency anemia are associated with increased morbidity and mortality in a wide range of conditions. In many patient populations, this can be treated effectively with oral iron supplementation; but in patients who are unable to take or who do not respond to oral iron thera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Macdougall, Iain C., Comin-Colet, Josep, Breymann, Christian, Spahn, Donat R., Koutroubakis, Ioannis E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467495/ https://www.ncbi.nlm.nih.gov/pubmed/32297281 http://dx.doi.org/10.1007/s12325-020-01323-z

Ejemplares similares

Systematic review and meta‐analysis of intravenous iron‐carbohydrate complexes in HFrEF patients with iron deficiency
por: Sindone, Andrew, et al.
Publicado: (2022)

Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management
por: Cappellini, Maria Domenica, et al.
Publicado: (2017)

Iron deficiency in chronic heart failure: case‐based practical guidance
por: Lam, Carolyn S. P., et al.
Publicado: (2018)

Practical Guidance for Diagnosing and Treating Iron Deficiency in Patients with Heart Failure: Why, Who and How?
por: Sindone, Andrew, et al.
Publicado: (2022)

Efficacy and safety of intravenous iron sucrose in treating adults with iron deficiency anemia
por: Cançado, Rodolfo Delfini, et al.
Publicado: (2011)

Iron therapy for the treatment of iron deficiency in chronic heart failure: intravenous or oral?
por: McDonagh, Theresa, et al.
Publicado: (2015)

Not all anemia is solely due to iron deficiency
por: Rössler, Julian, et al.
Publicado: (2020)

Questions and answers on iron deficiency treatment selection and the use of intravenous iron in routine clinical practice
por: Richards, Toby, et al.
Publicado: (2021)

Iron isomaltoside is superior to iron sucrose in increasing hemoglobin in gynecological patients with iron deficiency anemia
por: Derman, Richard, et al.
Publicado: (2018)

A randomized trial of iron isomaltoside versus iron sucrose in patients with iron deficiency anemia
por: Derman, Richard, et al.
Publicado: (2017)

Iron Deficiency in CKD Without Concomitant Anemia
por: Wish, Jay B., et al.
Publicado: (2021)

Association Between Norepinephrine Levels and Abnormal Iron Status in Patients With Chronic Heart Failure: Is Iron Deficiency More Than a Comorbidity?
por: Moliner, Pedro, et al.
Publicado: (2019)

Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives
por: Jankowska, Ewa A., et al.
Publicado: (2013)

Randomized Controlled Trial Comparing Ferrous Sulfate and Iron Sucrose in Iron Deficiency Anemia in Pregnancy
por: Chauhan, Neha, et al.
Publicado: (2023)

Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency(†)
por: Ponikowski, Piotr, et al.
Publicado: (2015)

A randomized, open-label trial of iron isomaltoside 1000 (Monofer®) compared with iron sucrose (Venofer®) as maintenance therapy in haemodialysis patients
por: Bhandari, Sunil, et al.
Publicado: (2015)

Patient Blood Management in Pregnancy
por: Kaserer, Alexander, et al.
Publicado: (2023)

Safety and Efficacy of Intravenous Iron Sucrose for Iron-Deficiency Anemia in Children and Adolescents With Inflammatory Bowel Disease
por: Sabe, Ramy, et al.
Publicado: (2019)

Safety of ferric derisomaltose and iron sucrose in patients with iron deficiency anemia: The FERWON‐IDA/NEPHRO trials
por: Wolf, Myles, et al.
Publicado: (2020)

Recalcitrant pyoderma gangrenosum treated with parenteral iron sucrose therapy
por: Buhalog, Brittany, et al.
Publicado: (2015)

Beyond the cardiorenal anaemia syndrome: recognizing the role of iron deficiency
por: Macdougall, Iain C., et al.
Publicado: (2012)

Efficacy and cost effectiveness of intravenous ferric carboxymaltose versus iron sucrose in adult patients with iron deficiency anaemia
por: Basha, Ahmad, et al.
Publicado: (2021)

Iron Sucrose Versus Oral Iron Therapy in Pregnancy Anemia
por: Neeru, Syal, et al.
Publicado: (2012)

Conversion of haemodialysis patients from iron sucrose to iron isomaltoside: a real-world experience
por: Jesus-Silva, Jorge A., et al.
Publicado: (2020)

Comparison of ferric Carboxymaltose and iron sucrose complex for treatment of iron deficiency anemia in pregnancy- randomised controlled trial
por: Jose, Ambily, et al.
Publicado: (2019)

The Impact of Intravenous Iron on Renal Injury and Function Markers in Patients With Chronic Kidney Disease and Iron Deficiency Without Anemia
por: Kassianides, Xenophon, et al.
Publicado: (2021)

Effects of iron deficiency and exogenous sucrose on the intermediates of chlorophyll biosynthesis in Malus halliana
por: Guo, Aixia, et al.
Publicado: (2020)

Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status
por: Comín-Colet, Josep, et al.
Publicado: (2013)

Safety of intravenous iron isomaltoside for iron deficiency and iron deficiency anemia in pregnancy
por: Wesström, Jan
Publicado: (2020)

Intravenous iron therapy in patients with chronic kidney disease: recent evidence and future directions
por: Macdougall, Iain C
Publicado: (2017)

Effectiveness and safety of ferric carboxymaltose compared to iron sucrose in women with iron deficiency anemia: phase IV clinical trials
por: Naqash, Amreen, et al.
Publicado: (2018)

Efficacy and safety of ferric derisomaltose (FDI) compared with iron sucrose (IS) in patients with iron deficiency anemia after bariatric surgery
por: Auerbach, Michael, et al.
Publicado: (2022)

Importance of iron deficiency in patients with chronic heart failure as a predictor of mortality and hospitalizations: insights from an observational cohort study
por: González-Costello, José, et al.
Publicado: (2018)

The Ferumoxytol for Anemia of CKD Trial (FACT)—a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale
por: Macdougall, Iain C., et al.
Publicado: (2017)

Screening, diagnosis and treatment of iron deficiency in chronic heart failure: putting the 2016 European Society of Cardiology heart failure guidelines into clinical practice
por: McDonagh, Theresa, et al.
Publicado: (2018)

Iron-Refractory Iron Deficiency Anemia
por: Yılmaz Keskin, Ebru, et al.
Publicado: (2015)

A prospective, multi‐center, randomized comparison of iron isomaltoside 1000 versus iron sucrose in patients with iron deficiency anemia; the FERWON‐IDA trial
por: Auerbach, Michael, et al.
Publicado: (2019)

Rationale and design of Ferinject(®) Assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia
por: Anker, Stefan D., et al.
Publicado: (2009)

Correction to: The Ferumoxytol for Anemia of CKD Trial (FACT)—a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale
por: Macdougall, Iain C., et al.
Publicado: (2018)

Fatal anaphylactic reaction to iron sucrose in pregnancy: Iron-induced Kounis syndrome?
por: Soufras, George D., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_75sbvidv35f11fsjpq8i9gl5q2